Components of Expenses

12 Months Ended

Dec. 31, 2024

Analysis of income and expense [abstract]


	2024		2023		2022
Research and development expenses
Clinical trial expenses	$	5,463	$	3,675	$	4,970
Manufacturing & related process development expenses	8,267		5,789		2,148
Intellectual property expenses	433		397		544
Translational science expenses	101		—		264
Personnel-related expenses	5,451		6,324		6,023
Share-based compensation expense	1,717		1,305		1,371
Other expenses	215		219		112
	$	21,647	$	17,709	$	15,432

General and administrative expenses
Public company-related expenses	$	8,565	$	11,278	$	6,790
Personnel-related expenses	2,848		3,332		2,870
Office expenses	492		457		433
Share-based compensation expense	1,006		612		1,007
Depreciation - property and equipment	120		81		93
Depreciation - right-of-use assets	304		322		299
	$	13,335	$	16,082	$	11,492

For the year ended December 31, 2024, our research and development personnel-related expenses included employee compensation and benefits of $5,328 (2023 - $6,324; 2022 - $5,983).

For the year ended December 31, 2024, our general and administrative office expenses included employee compensation and benefits of $2,650 (2023 - $3,332; 2022 - $2,870).